Skip to content
10-Q

Quarterly Report

Apyx Medical Corp APYX

0001437749-26-015652

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 6, 2026 41.87M sh
Capex Q1 2026 · Mar 31, 2026 $60K
Capex Q1 2026 · Mar 31, 2025 $55K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$572K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$702K
Long Term Debt Q1 2026 · Mar 31, 2026 $35.09M
Long Term Debt Q1 2026 · Dec 31, 2025 $34.85M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $31.14M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $31.74M
Stockholders Equity Q1 2026 · Mar 31, 2026 $12.83M
Stockholders Equity Q1 2026 · Dec 31, 2025 $14.54M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.45M
Current Liabilities Q1 2026 · Dec 31, 2025 $11.7M
Total Liabilities Q1 2026 · Mar 31, 2026 $49.94M
Total Liabilities Q1 2026 · Dec 31, 2025 $52.01M
Current Assets Q1 2026 · Mar 31, 2026 $54.8M
Current Assets Q1 2026 · Dec 31, 2025 $58.47M
Total Assets Q1 2026 · Mar 31, 2026 $63.03M
Total Assets Q1 2026 · Dec 31, 2025 $66.84M
Eps Basic Q1 2026 · Mar 31, 2026 −$0.05
Eps Basic Q1 2026 · Mar 31, 2025 −$0.10
Sga Expense Q1 2026 · Mar 31, 2026 $3.58M
Sga Expense restated Q1 2026 · Mar 31, 2025 $3.47M
Rd Expense Q1 2026 · Mar 31, 2026 $765K
Rd Expense Q1 2026 · Mar 31, 2025 $804K
Net Income Q1 2026 · Mar 31, 2026 −$2.11M
Net Income Q1 2026 · Mar 31, 2025 −$4.15M
Operating Income Q1 2026 · Mar 31, 2026 −$911K
Operating Income Q1 2026 · Mar 31, 2025 −$3.05M
Gross Profit Q1 2026 · Mar 31, 2026 $7.93M
Gross Profit Q1 2026 · Mar 31, 2025 $5.67M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $4.57M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $3.77M
Revenue Q1 2026 · Mar 31, 2026 $12.49M
Revenue Q1 2026 · Mar 31, 2025 $9.43M